MedPath

Riluzole in the treatment of obsessive compulsive disorder

Phase 2
Conditions
Obsessive- Cumpulsive Disorder.
Obsessive-compulsive disorder
Registration Number
IRCT201211211556N48
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion Criteria: 1-Age between 18-60, 2-Diagnosis of OCD based on DSM IV 3 , Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale-

Exclusion Criteria

1- Substance dependence,2- IQ less than 70,3-any other mental disorder on axis I, 4-Any serious cardiac, renal or hepatic disease ,5- receiving psychotropic medications during the last 6 weeks 6- pregnancy or breast feeding 7-rising liver transaminases to three times the upper limit of normal or highe

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath